As of 2025-06-23, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (10.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -660.9%.
The range of the Relative Valuation is (11.07) - (10.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 11.0x | 9.1x |
| Forward P/E multiples | 11.4x - 17.0x | 12.7x |
| Fair Price | (11.07) - (10.60) | (10.54) |
| Upside | -688.7% - -664.0% | -660.9% |
| Date | P/E |